The Group invested in a well-known anti-cancer drug R & D company in Yunnan to help it carry out continuous research and development of anti-cancer drugs. The enterprise is a high-tech pharmaceutical enterprise specializing in the R & D, production and sales of anti-cancer drugs for ethnic minorities in China. It has obtained the national drug production license, drug GMP certificate, ISO9001 international quality system certification, ISO4001 international environmental quality certification, foreign trade import and export rights, the approval for imported drugs issued by the Ministry of Health of Egypt and the post doctoral scientific research sub station approved by the Ministry of Personnel.
Innovative research and development of anticancer drugs
2022-12-28 09:03:35 70The Group invested in a well-known anti-cancer drug R & D company in Yunnan to help it carry out continuous research and development of anti-cancer drugs.
